FRAZER, Pa., Feb. 4 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that Sarma P. Duddu, Ph.D., has been appointed as General Manager and Vice President of Drug Delivery Technologies of CIMA LABS, Inc. In this role, Dr. Duddu will lead all aspects of the Cephalon drug delivery business at CIMA, its wholly owned drug delivery subsidiary located in suburban Minnesota.
In his new role, Dr. Duddu will be a member of the Cephalon Technical Operations leadership team and will report directly to Peter E. Grebow, Ph.D., Executive Vice President of Worldwide Technical Operations.
"We are pleased with the strong record of successful drug development that Sarma brings to our organization," said Peter Grebow, Ph.D., Executive Vice President Worldwide Technical Operations. "His extensive experience in drug delivery and previous leadership roles in R&D, product development and new product research make him well qualified to not only lead, but to strengthen and grow our drug delivery business."
Dr. Duddu has more than 15 years of pharmaceutical experience and has been involved in all aspects of the drug delivery business. Most recently, he held the position of vice president of pharmaceutical development at Nektar Therapeutics (formerly Inhale Therapeutic Systems) based in San Carlos, CA. Previously at Nektar, Dr. Duddu held key management positions in product development, R&D operations, corporate development and strategy, as well as new product research. Prior to Nektar, he worked at SmithKline Beecham Pharmaceuticals in King of Prussia, PA, where he focused in the areas of phar
|SOURCE Cephalon, Inc.|
Copyright©2009 PR Newswire.
All rights reserved